Haren, Frank M.P. van 
; Richardson, Alice ; Yoon, Hwan‐Jin ; Artigas, Antonio ; Laffey, John G. ; Dixon, Barry; Smith, Roger; Vilaseca, Alicia B. ; Barbera, Ruben A.; Ismail, Tarek I.; Mahrous, Rabab S. ; Badr, Mohamed ; De Nucci, Gilberto ; Sverdloff, Carlos; Loon, Lex M. van ; Rimblas, Marta Camprubi ; Cosgrave, David W. ; Smoot, Thomas L. ; Staas, Sabrina; Sann, Khine ; Sas, Caitlin; Belani, Anusha; Hillman, Christopher; Shute, Janis ; Carroll, Mary; Wilkinson, Tom ; Carroll, Miles ; Singh, Dave; Page, Clive
Source: British Journal of Clinical Pharmacology (Print). Unidade: ICB
Subjects: FARMACOLOGIA, COVID-19, DOENÇAS RESPIRATÓRIAS, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO, POLISSACARÍDEOS, INFECÇÕES RESPIRATÓRIAS, INFECÇÕES POR VÍRUS DE RNA, INFECÇÕES POR CORONAVIRUS
ABNT
HAREN, Frank M.P. van et al. INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID‐19 (INHALE‐HEP): protocol and statistical analysis plan for an investigator‐initiated international metatrial of randomised studies. British Journal of Clinical Pharmacology (Print), p. 1-17, 2021Tradução . . Disponível em: https://doi.org/10.1111/bcp.14714. Acesso em: 05 nov. 2024.APA
Haren, F. M. P. van, Richardson, A., Yoon, H. ‐J., Artigas, A., Laffey, J. G., Dixon, B., et al. (2021). INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID‐19 (INHALE‐HEP): protocol and statistical analysis plan for an investigator‐initiated international metatrial of randomised studies. British Journal of Clinical Pharmacology (Print), 1-17. doi:10.1111/bcp.14714NLM
Haren FMP van, Richardson A, Yoon H‐J, Artigas A, Laffey JG, Dixon B, Smith R, Vilaseca AB, Barbera RA, Ismail TI, Mahrous RS, Badr M, De Nucci G, Sverdloff C, Loon LM van, Rimblas MC, Cosgrave DW, Smoot TL, Staas S, Sann K, Sas C, Belani A, Hillman C, Shute J, Carroll M, Wilkinson T, Carroll M, Singh D, Page C. INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID‐19 (INHALE‐HEP): protocol and statistical analysis plan for an investigator‐initiated international metatrial of randomised studies [Internet]. British Journal of Clinical Pharmacology (Print). 2021 ; 1-17.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/bcp.14714Vancouver
Haren FMP van, Richardson A, Yoon H‐J, Artigas A, Laffey JG, Dixon B, Smith R, Vilaseca AB, Barbera RA, Ismail TI, Mahrous RS, Badr M, De Nucci G, Sverdloff C, Loon LM van, Rimblas MC, Cosgrave DW, Smoot TL, Staas S, Sann K, Sas C, Belani A, Hillman C, Shute J, Carroll M, Wilkinson T, Carroll M, Singh D, Page C. INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID‐19 (INHALE‐HEP): protocol and statistical analysis plan for an investigator‐initiated international metatrial of randomised studies [Internet]. British Journal of Clinical Pharmacology (Print). 2021 ; 1-17.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/bcp.14714
